PARP inhibitors and quality of life in ovarian cancer

Research output: Contribution to journalComment/debate

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)1012-1014
Number of pages3
JournalThe Lancet Oncology
Volume19
Issue number8
DOIs
Publication statusPublished - 2018 Aug 1

Fingerprint

Ovarian Neoplasms
Quality of Life
Poly(ADP-ribose) Polymerase Inhibitors

ASJC Scopus subject areas

  • Oncology

Cite this

PARP inhibitors and quality of life in ovarian cancer. / Aoki, Daisuke; Chiyoda, Tatsuyuki.

In: The Lancet Oncology, Vol. 19, No. 8, 01.08.2018, p. 1012-1014.

Research output: Contribution to journalComment/debate

@article{e45d1d5b3b444fabbfd5f80e2a824f0b,
title = "PARP inhibitors and quality of life in ovarian cancer",
author = "Daisuke Aoki and Tatsuyuki Chiyoda",
year = "2018",
month = "8",
day = "1",
doi = "10.1016/S1470-2045(18)30435-2",
language = "English",
volume = "19",
pages = "1012--1014",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "8",

}

TY - JOUR

T1 - PARP inhibitors and quality of life in ovarian cancer

AU - Aoki, Daisuke

AU - Chiyoda, Tatsuyuki

PY - 2018/8/1

Y1 - 2018/8/1

UR - http://www.scopus.com/inward/record.url?scp=85053841084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053841084&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(18)30435-2

DO - 10.1016/S1470-2045(18)30435-2

M3 - Comment/debate

VL - 19

SP - 1012

EP - 1014

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 8

ER -